Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M210Revenue $M42.6Net Margin (%)33.9Altman Z-Score-0.8
Enterprise Value $M64.6EPS $0.8Operating Margin %-240.8Piotroski F-Score3
P/E(ttm)10.1Beneish M-Score1.9Pre-tax Margin (%)-245.7Higher ROA y-yY
Price/Book1.110-y EBITDA Growth Rate %--Quick Ratio5.4Cash flow > EarningsN
Price/Sales4.05-y EBITDA Growth Rate %--Current Ratio5.7Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %-333.8ROA % (ttm)6.8Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)16.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M24.8ROIC % (ttm)-272.4Gross Margin Increase y-yN

Gurus Latest Trades with ZGNX

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

ZGNX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ZGNX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HAWLEY ROGERDirector 2015-12-15Buy10,000$13.74-38.21view
HAWLEY ROGERDirector 2015-12-15Buy10,000$13.74-38.21view
TANNENBAUM RENEE PDirector 2015-12-03Buy5,000$15.4-44.87view
HAWLEY ROGERDirector 2015-06-16Buy50,000$1.59433.96view
HAWLEY ROGERCEO 2015-03-16Buy140,000$1.31548.09view
GARNER CAM LDirector 2014-06-13Buy30,000$1.66411.45view
Shively Richard ScottChief Commercial Officer 2014-06-03Sell19,229$2.1304.29view
RHOADS ANN DEVP, CFO, Treasurer & Sec. 2014-06-03Sell19,229$2.1304.29view
HAWLEY ROGERCEO 2014-06-03Sell25,078$2.1304.29view
FARR STEPHEN JPresident and COO 2014-06-03Sell20,900$2.1304.29view

Quarterly/Annual Reports about ZGNX:

News about ZGNX:

Articles On GuruFocus.com
Analysts Weigh in on Zogenix in Light of Selling Zohydro Mar 12 2015 
Weekly CFO Buys Highlight: NGL, UNTK, ZGNX, VTSS, RVSB Dec 24 2012 
(ZGNX) CEO Roger Hawley buys 10,000 Shares Dec 06 2010 

More From Other Websites
Zogenix to Participate in LEERINK Partners 5th Annual Global Healthcare Conference Feb 03 2016
Zogenix Receives Fast Track Designation From FDA for Development of ZX008 in Dravet Syndrome Jan 19 2016
ZOGENIX, INC. Files SEC form 8-K, Other Events Jan 19 2016
Zogenix Receives Fast Track Designation From FDA for Development of ZX008 in Dravet Syndrome Jan 19 2016
Buffett Buys More Shares of This Energy Company, Carlson Reaches Agreement With Vitamin Shoppe Inc.... Jan 14 2016
Healthcare Sector Equities under Review -- Amarin, Arrowhead Research, Zogenix, and PetMed Express Jan 13 2016
Zogenix Announces Initiation of Phase 3 Program for ZX008 in Dravet Syndrome Jan 11 2016
ZOGENIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Jan 11 2016
Zogenix Announces Initiation of Phase 3 Program for ZX008 in Dravet Syndrome Jan 11 2016
Zogenix, Inc. breached its 50 day moving average in a Bearish Manner : January 5, 2016 Jan 05 2016
Where We Are Headed - Analyst Notes on Harmonic, Zogenix, Hutchinson Technology and Pfenex Dec 24 2015
Zogenix, Inc. Earnings Analysis: Q3, 2015 By the Numbers Dec 22 2015
Healthcare Sector Equities under the Scanner -- Zogenix, Amarin, SciClone Pharma, and PetMed Express Dec 18 2015
ZOGENIX, INC. Files SEC form 8-K, Other Events Dec 14 2015
Zogenix Announces FDA Acceptance of Investigational New Drug Application for ZX008 Phase 3 Clinical... Dec 14 2015
Zogenix Announces FDA Acceptance of Investigational New Drug Application for ZX008 Phase 3 Clinical... Dec 14 2015
NewBridge Bancorp (NBBC): Hedge Funds Are Snapping Up Dec 12 2015
Timing is Crucial, Upside Analysis - Free Research Reports on Walter Investment Management,... Dec 11 2015
ZOGENIX, INC. Financials Dec 08 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK